Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters

Database
Language
Publication year range
1.
Gene ; 163(2): 289-94, 1995 Oct 03.
Article in English | MEDLINE | ID: mdl-7590283

ABSTRACT

A domain substitution experiment was carried out between the structurally related DNA-polymerizing enzymes Pol beta and TdT to investigate the region of Pol beta required for template utilization. Site-directed mutagenesis and recombinant DNA procedures were used for construction of a gene encoding a chimeric form of the two enzymes and termed TDT::POLB, in which the DNA region encoding amino acids (aa) 154-212 of TdT was replaced by the corresponding region encoding aa 1-60 of POL beta. The construction was confirmed by restriction analysis and DNA sequencing. Since this region of POL beta represents most of the N-terminal domain of the enzyme possessing single-stranded DNA (ssDNA)-binding activity, it was hypothesized that the chimeric protein, unlike TdT, might possess template-dependent DNA polymerase activity. The chimeric gene product was produced in Escherichia coli, purified and subjected to preliminary enzymological characterization. The finding that the chimeric TdT::Pol beta protein possessed significant template-dependent polymerase activity suggests that aa 1-60 of Pol beta are involved in template utilization during the polymerization reaction, as suggested by the previous finding that the 8-kDa N-terminal domain of Pol beta possesses ssDNA-binding activity [Kumar et al., J. Biol. Chem. 265 (1990a) 2124-2131; Kumar et al., Biochemistry 29 (1990b) 7156-7159; Prasad et al., J. Biol. Chem. 268 (1993) 22746-22755].


Subject(s)
DNA Nucleotidylexotransferase/genetics , DNA Polymerase I/genetics , Amino Acid Sequence , DNA Nucleotidylexotransferase/biosynthesis , DNA Polymerase I/biosynthesis , Escherichia coli/genetics , Escherichia coli/metabolism , Genetic Engineering , Humans , Molecular Sequence Data , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/genetics , Sequence Alignment
2.
Biochem Pharmacol ; 54(3): 419-24, 1997 Aug 01.
Article in English | MEDLINE | ID: mdl-9278101

ABSTRACT

6-Thioguanine (S6G) has been used in the treatment of acute leukemias because of its cytotoxic effect on proliferating leukemic cells. The cytotoxicity of S6G is thought to derive from its incorporation into DNA in place of guanine. The deoxyribonucleoside triphosphate of S6G, SdGTP, is a good substrate for bacterial and human DNA polymerases (Ling et al., Mol Pharmacol 40: 508-514, 1991). Since SdGTP was observed to misincorporate in place of adenine at a greater frequency than did dGTP, it appeared plausible that this analog could produce more subtle effects (mutations) due to mispairing with thymine. To assess whether such mutations occur, SdGTP was incorporated into the lacI gene of phage M13lacISaXb in reactions that omitted dGTP (-G) or dATP (-A). LacI mutation frequency was determined by beta-galactosidase colorimetric staining (inactivation of the lac repressor results in blue plaques in the absence of inducer). When a high concentration of SdGTP (24 microM) was used in the DNA polymerase reaction, phage infectivity was inhibited. When a relatively low concentration (2.4 nM) was added to the -G and -A reactions, mutagenic effects were observed. DNA sequencing of mutant progeny arising from the -G + S6G reaction revealed C-to-T base transitions and some C-to-A transversions. Similarly, the presence of SdGTP in the -A reactions led to mutants with T-to-C transitions. No insertions or deletions were observed. These data indicate that mispairing of S6G with thymine leads to mutagenic effects in this assay.


Subject(s)
DNA/genetics , Deoxyguanine Nucleotides/metabolism , Escherichia coli Proteins , Thioguanine/metabolism , Thionucleotides/metabolism , Bacterial Proteins/genetics , DNA/biosynthesis , DNA Replication , Escherichia coli/genetics , Lac Repressors , Mutagens , Mutation , Repressor Proteins/genetics
3.
Rev Latinoam Microbiol ; 35(4): 433-41, 1993.
Article in English | MEDLINE | ID: mdl-8066336

ABSTRACT

The mutagenic role of 1-N6-Ethenodeoxydenosine (epsilon A) was assessed by a genetic assay of mutations in the 5' coding region of the lacl gene of Escherichia coli. 1-N6-Etheno-2-deoxydadenosine 5'-triphosphate (epsilon dATP) was substituted for dATP during in vitro DNA synthesis on M13 recombinant uracil single stranded DNA bearing the lacl gene, catalyzed by the large fragment of E. coli DNA polymerase I. DNA products were transfected into a strain of E. coli lacking a chromosomal copy of the lacl gene, and i- phenotypic mutants were seen as blue plaques in the absence of inducer. Mutant progeny were characterized by dideoxy sequencing in the N-terminal region of the lacl gene where epsilon A had originally replaced A, and were found to have T-->C transitions. The frequency of base substitution mutation was different in each of three target sites tested. Taking into account the sequence changes and the coding properties at target sites, we conclude that in general, epsilon A increases the mutation frequency when compared with the control (transfection with unsubstituted DNA). This increase was similar to that produced by in vitro primer elongation in absence of dATP. The combined results of the electrophoretic assay of primer elongation, measurements of mutation frequency, and sequence analysis of mutant phage progeny support the proposal that epsilon A in template DNA can be mutagenic through epsilon AC mispairing during in vivo replication.


Subject(s)
DNA, Bacterial/genetics , Deoxyadenosines/genetics , Mutagenesis , Base Composition , Base Sequence , Codon/genetics , DNA Primers , DNA, Bacterial/chemistry , Escherichia coli/genetics , Genes, Bacterial , Molecular Sequence Data , Templates, Genetic
4.
Immunology ; 100(1): 21-8, 2000 May.
Article in English | MEDLINE | ID: mdl-10809955

ABSTRACT

Lactoferrin (LF) is a member of the transferrin family of iron-binding glycoproteins to which several anti-inflammatory functions have been ascribed. LF has been shown to down-regulate expression of the pro-inflammatory cytokine tumour necrosis factor-alpha (TNF-alpha), although the possibility has been raised that the activity of LF in this regard was indirect and secondary to its ability to bind to and inactivate the bacterial lipopolysaccharide (LPS) used to induce cytokine production. However, the identification of putative membrane receptors for LF raises the possibility that the interaction of LF with its receptor may be one important route through which this protein exerts anti-inflammatory activity. In the present investigations the biological properties of LF have been examined in a model of cutaneous immune function where the allergen-induced migration of epidermal Langerhans cells (LC) from the skin and their subsequent accumulation as dendritic cells (DC) in skin-draining lymph nodes are known to be dependent upon the de novo synthesis of TNF-alpha, but independent of exogenous LPS. Consistent with the protein having direct anti-inflammatory properties, it was found that the intradermal injection of recombinant murine LF (either iron-saturated or iron-depleted LF) inhibited significantly allergen (oxazolone) -induced LC migration and DC accumulation. That these inhibitory effects were secondary to the inhibition of local TNF-alpha synthesis was suggested by the findings that first, LF was unable to inhibit LC migration induced by intradermal injection of TNF-alpha itself, and second, that migration stimulated by local administration of another epidermal cytokine, interleukin 1beta, which is also dependent upon TNF-alpha production, was impaired significantly by prior treatment with LF. Finally, immunohistochemical analyses demonstrated the presence of LF in skin, associated primarily with keratinocytes. Collectively these data support the possession by LF of direct immunomodulatory and/or anti-inflammatory activity, probably associated in this case with inhibition of cytokine production. Furthermore, the results suggest that as a constituent of normal skin, LF may play a role in homeostatic regulation of cutaneous immune function.


Subject(s)
Epidermis/immunology , Lactoferrin/pharmacology , Langerhans Cells/drug effects , Allergens/immunology , Animals , Cell Movement/drug effects , Cell Movement/immunology , Interleukin-1/immunology , Iron/pharmacology , Lactoferrin/metabolism , Langerhans Cells/immunology , Lymph Nodes/immunology , Male , Mice , Mice, Inbred BALB C , Oxazolone/immunology , Skin/metabolism , Tumor Necrosis Factor-alpha/immunology
5.
Rev Latinoam Microbiol ; 44(2): 58-64, 2002.
Article in English | MEDLINE | ID: mdl-17063772

ABSTRACT

The aim of this work was to search if the rat DNA polymerase beta can substitute the capability of DNA polymerase I to repair damage caused by the UV light in Escherichia coli. The oriC origin of replication from p beta 5 was replaced by the rep origin from pSC101 and named p beta 6. The presence of pol beta in the new construct was verified by PCR. E. coli polA-1 (WP6) was transformed with p beta 6. A protein with size similar to DNA Pol beta (40 kDa) was shown in the cell free extracts carrying pbeta5. In WP6/p beta 6 cell free extracts a slightly smaller protein was observed instead of the 40 kDa. DNA Pol beta was revealed by western analysis, with polyclonal antibodies, in strains with p beta 5. Yet, it was not detected in the western from WP6/p beta 6. A moderate change in UV resistance was observed in strains carrying p beta 5. However, in polAl carrying p beta 6 (WP6/p beta 6), irradiated with 60-90 J/m2 of UV light, the viability was increased by more than four orders of magnitude, when compared with the polA1 (WP6) strain, reaching approximately the same UV resistance as the strains with DNA polymerase I. The results suggests that probably Pol beta is rapidly degraded in the cell free extracts from WP6/p beta 6 and, it repairs the lethal effect of the UV light in E. coli.


Subject(s)
DNA Damage/genetics , DNA Polymerase I/physiology , DNA Polymerase beta/physiology , DNA Repair , Ultraviolet Rays/adverse effects , Animals , Rats
SELECTION OF CITATIONS
SEARCH DETAIL